Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support and Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regard to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in regard to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards legislation to respond to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in opposition to the Build Back Better reconciliation bill (H.R. 5376). H.R. 5376 contains numerous provisions to fund elective abortion in violation of the longstanding principles of the Hyde Amendment, would mandate abortion funding in Affordable Care Act (Obamacare) plans in states that did not expand Medicaid in 2024, and direct billions of dollars to various public health grants without Hyde Amendment protections. Contacts in opposition to the Right to Contraception Act (H.R. 8373) which includes provisions related to the funding of abortion providers and includes language that could permit the use of drugs to induce an abortion weeks or months into a pregnancy. Contacts in opposition to H. Res. 1434 dealing with the preemption of state law in regard to abortion drugs. Contacts regarding H. R. 6878, the Pregnant Women in Custody Act, as it relates to travel for abortion. No position taken.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reproductive Rights and Roe v. Wade; State abortion bans and abortion access in the United States; Administrative actions to protect and expand abortion access; Administrative action to declare a national and public health emergency over Americans access to reproductive care following Dobbs v. Jackson Women Health Organization; Access to abortion care for workers; Access to information and resources for people seeking abortion care and reproductive health services; Access to abortion, contraception, and maternity care for veterans, servicemembers, and dependents; H.R. 8916, the Access to Reproductive Care for Servicemembers Act, regarding leave policies for servicemembers to seek abortion care; Interim final rule on veterans access to reproductive health services; H.R. 7900, FY23 National Defense Authorization Act; Access to the contraceptive coverage benefit under the Affordable Care Act; Access to contraceptives and reproductive health care without cost-sharing for TRICARE enrollees; Title X family planning program; H.R. 8424 and S. 4550, Expanding Access to Family Planning Act, Access to over-the-counter contraception; Trump administration refusal of care rule; Denials of and nondiscrimination in healthcare; Rescission of the refusal of care rule; Rules implementing Section 1557 of the Affordable Care Act; Treatment of pregnant incarcerated people and detainees; Maternal health outcomes and care options; Paid family and medical leave; LGBTQ+ rights; H.Res. 1209, recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights; H.R. 804 and S. 248, FAMILY Act, regarding paid family leave; H.R. 1065 and S. 1486, the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers; H.R. 5 and S. 393, the Equality Act, regarding ending discrimination for LGBTQIA+ individuals; H.R. 2234 and S. 1021, the EACH Act of 2021, regarding access to affordable health insurance plans that cover abortion; H.R. 3755, H.R. 8296, S.4132, and S. 1975, the Women's Health Protection Act, regarding access to abortion care; S. 3713, the Reproductive Choice Act, regarding limited access to abortion care; H.R. 8297, the Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to access reproductive healthcare; H.R. 8452, the Reproductive Health Travel Fund Act of 2022, regarding financial support for people traveling to access abortion care; H.R. 8373 and S.4557, the Right to Contraception Act, regarding the an individuals right to use and provide contraceptives and related counseling; H.R. 8650 and S. 4723, the Let Doctors Provide Reproductive Health Care Act, regarding protections for healthcare providers; H.Con.Res. 109, Concurrent Resolution, regarding support for the recognition of September 26, 2022, as World Contraception Day and expressing the sense of the House of Representatives regarding global and domestic access to contraception; H.R. 9040 and S.4764, the Reproductive Health Care Accessibility Act, regarding expanding access to reproductive health care for people with disabilities; S. 4688, the Reproductive Freedom for All Act, regarding reproductive health decisions; S. 4840, the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, regarding restricting access to abortion; Access to evidence-based medication abortion care; H.Res. 1434, regarding access to reproductive health care by reaffirming the Food and Drug Administrations (FDA) authority to preempt state law and ensure access to reproductive health care products; Criminalization of pregnancy outcomes or essential healthcare services; H.Con.Res. 89, Concurrent Resolution, regarding the criminalization of essential health care, including the full range of sexual and reproductive health care such as abortion; Healthcare data privacy; H.R. 8111, My Body, My Data Act of 2022, regarding data privacy; Moderation of abortion mis-and disinformation by social media companies; Free choice of provider in Medicaid programs; Violence against women; S. 3623 and H.R. 1620, Violence Against Women Reauthorization Act of 2022.